116 filings
Page 2 of 6
8-K
1c3fu5v3kw35
7 Nov 22
Cara Therapeutics Reports Third Quarter 2022 Financial Results
4:10pm
8-K
q5do01s20v5 msk
3 Nov 22
Cara Therapeutics Announces Appointment of Lisa von Moltke, M.D., to its Board of Directors
7:12am
8-K
zhn01n1 7i1o0ch
12 Sep 22
Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer
6:01am
8-K
mx46nqh4u2cs 83b
8 Aug 22
Cara Therapeutics CORPORATE PRESENTATION AUGUST 2022
4:11pm
8-K
w5dwf5qmzmitdl0bcw
8 Aug 22
Cara Therapeutics Reports Second Quarter 2022 Financial Results
4:11pm
8-K
g2bodr
30 Jun 22
Regulation FD Disclosure
7:01am
8-K
fxl0i
7 Jun 22
Submission of Matters to a Vote of Security Holders
5:30pm
8-K
25m1 8v56sekf
3 Jun 22
Departure of Directors or Certain Officers
4:30pm
8-K
1eufbqa h83p1myv
9 May 22
Cara Therapeutics Reports First Quarter 2022 Financial Results
4:10pm
8-K
0zp65qh
11 Mar 22
Cara Therapeutics CORPORATE PRESENTATION MARCH 2022
4:30pm
8-K
247csdd6ksy gff
1 Mar 22
Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
4:10pm
8-K
nst1 nsoo
10 Jan 22
Results of Operations and Financial Condition
7:00am
8-K
afnu8
21 Dec 21
Departure of Directors or Certain Officers
4:30pm
8-K
6rodhbds
20 Dec 21
Cara Therapeutics Announces CMS Grants TDAPA to KORSUVA™ (difelikefalin) Injection
7:00am
8-K
dths2an
8 Nov 21
Cara Therapeutics Reports Third Quarter 2021 Financial Results
4:10pm
8-K
p9ra 9sl9
3 Nov 21
Cara Therapeutics Announces CEO Transition
8:10am
8-K
cn1dgld
31 Aug 21
Other Events
12:00am
8-K
4gchncpb
23 Aug 21
Other Events
4:44pm
8-K
yj6i76u7dil3 vck2
12 Aug 21
Regulation FD Disclosure
8:03am
8-K
et36z5wysro6hafsue8a
9 Aug 21
Cara Therapeutics Reports Second Quarter 2021 Financial Results
4:10pm